Fermata Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Fermata Advisors's LLY Position: Q2 2026 in Review
Fermata Advisors increased its Eli Lilly (LLY) stake by 34% in Q2 2026, buying an estimated $135K and bringing the position to 524 shares worth $629K. The position accounts for 0.13% of the portfolio, ranked #134.
Fermata Advisors first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.12M in Q3 2024. 767 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Fermata Advisors held 524 shares of Eli Lilly worth $629K as of Q2 2026.
- Fermata Advisors bought 132 Eli Lilly shares in Q2 2026, an estimated $135K.
- Eli Lilly made up 0.13% of Fermata Advisors's portfolio in Q2 2026, its #134 holding.
- Fermata Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
- Fermata Advisors's Eli Lilly position peaked at $1.12M in Q3 2024.
- 767 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Fermata Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.